EX-99.1

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to Common Stock, no par value per share, of Mirati Therapeutics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.


BOXER CAPITAL, LLC

By:		/s/Aaron I. Davis
Name:		Aaron I. Davis
Title:		Chief Executive Officer

BOXER ASSET MANAGEMENT INC.

By:		/s/ Jason Callender
Name:		Jason Callender
Title:		Director

BRASLYN LTD.

By:		/s/ Joseph C. Lewis
Name:		Joseph C. Lewis
Title:		Director

MVA INVESTORS, LLC

By:		/s/ Aaron I. Davis
Name:		Aaron I. Davis
Title:		Authorized Signatory

JOSEPH C. LEWIS

By:		/s/ Joseph C. Lewis
		Joseph C. Lewis, Individually

IVAN M. LIEBERBURG

By:		/s/ Christopher Fuglesang
		Christopher Fuglesang, Attorney-in-Fact

AARON I. DAVIS

By:		/s/ Aaron I. Davis
		Aaron I. Davis, Individually

SHEHAN B. DISSANAYAKE

By:		/s/ Shehan B. Dissanayake
		Shehan B. Dissanayake, Individually


CHRISTOPHER FUGLESANG

By:		/s/ Christopher Fuglesang
		Christopher Fuglesang, Individually


CUSIP No. 60468T105		SCHEDULE 13D/A